Title:
Field-friendly anti-PGL-I serosurvey in children to monitor Mycobacterium leprae transmission in Bihar, India

dc.contributor.authorLouise Pierneef
dc.contributor.authorParitosh Malaviya
dc.contributor.authorAnouk van Hooij
dc.contributor.authorShyam Sundar
dc.contributor.authorAbhishek Kumar Singh
dc.contributor.authorRajiv Kumar
dc.contributor.authorDanielle de Jong
dc.contributor.authorMaaike Meuldijk
dc.contributor.authorAwnish Kumar
dc.contributor.authorZijie Zhou
dc.contributor.authorKristien Cloots
dc.contributor.authorPaul Corstjens
dc.contributor.authorEpco Hasker
dc.contributor.authorAnnemieke Geluk
dc.date.accessioned2026-02-07T11:37:00Z
dc.date.issued2023
dc.description.abstractBackground: It has been amply described that levels of IgM antibodies against Mycobacterium leprae (M. leprae) phenolic glycolipid I (PGL-I) correlate strongly with the bacterial load in an infected individual. These findings have generated the concept of using seropositivity for antibodies against M. leprae PGL-I as an indicator of the proportion of the population that has been infected. Although anti-PGL-I IgM levels provide information on whether an individual has ever been infected, their presence cannot discriminate between recent and past infections. Since infection in (young) children by definition indicates recent transmission, we piloted the feasibility of assessment of anti-PGL-I IgM seroprevalence among children in a leprosy endemic area in India as a proxy for recent M. leprae transmission. Material and methods: A serosurvey for anti-PGL-I IgM antibodies among children in highly leprosy endemic villages in Bihar, India, was performed, applying the quantitative anti-PGL-I UCP-LFA cassette combined with low-invasive, small-volume fingerstick blood (FSB). Results: Local staff obtained FSB of 1,857 children (age 3–11 years) living in 12 leprosy endemic villages in Bihar; of these, 215 children (11.58%) were seropositive for anti-PGL-I IgM. Conclusion: The anti-PGL-I seroprevalence level of 11.58% among children corresponds with the seroprevalence levels described in studies in other leprosy endemic areas over the past decades where no prophylactic interventions have taken place. The anti-PGL-I UCP-LFA was found to be a low-complexity tool that could be practically combined with serosurveys and was well-accepted by both healthcare staff and the population. On route to leprosy elimination, quantitative anti-PGL-I serology in young children holds promise as a strategy to monitor recent M. leprae transmission in an area. Copyright © 2023 Pierneef, Malaviya, van Hooij, Sundar, Singh, Kumar, de Jong, Meuldijk, Kumar, Zhou, Cloots, Corstjens, Hasker and Geluk.
dc.identifier.doi10.3389/fmed.2023.1260375
dc.identifier.issn2296858X
dc.identifier.urihttps://doi.org/10.3389/fmed.2023.1260375
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/46117
dc.publisherFrontiers Media SA
dc.subjectanti-M. leprae PGL-I antibodies
dc.subjectchildren
dc.subjectdiagnostics
dc.subjectinfection
dc.subjectleprosy
dc.subjectserosurvey
dc.subjecttransmission
dc.subjectupconversion
dc.titleField-friendly anti-PGL-I serosurvey in children to monitor Mycobacterium leprae transmission in Bihar, India
dc.typePublication
dspace.entity.typeArticle

Files

Collections